October 3, 2011
Roche has announced that it has received a positive opinion for its anticancer treatment Avastin (bevacizumab) from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) as a first-line treatment for women with advanced...read more